Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook




 

Genetic test for cancer may reduce need for screening

16 May 2011

By Dr Kimberley Bryon-Dodd

Appeared in BioNews 607

Screening for breast and prostate cancer based on genetic risk factors as well as age could reduce the number of people screened without a significant reduction in the number of cancers detected, a new study suggests.

'This is an alternative approach to the existing screening programme and might even have the potential to reduce over-diagnosis, and in turn, lower costs', said lead author Dr Nora Pashayan from the Department of Public Health and Primary Care, University of Cambridge.

Dr Pashayan and UK colleagues used a statistical model to examine the effect of offering screening to men and women based on their genetic risk factors as well as their age. They compared current screening approaches for breast and prostate cancer with the new model and found using the new model would have resulted in 24 percent (%) fewer women being screened and 14% fewer cases of breast cancer being detected. They also found 16% fewer men would be eligible for prostate cancer screening but only 3% fewer cases would be detected.

'For our model to be used women would need to have a genetic test before the age of 35', said Dr Pashayan, explaining how the approach would work in breast cancer screening. 'This would be a simple blood test to identify genetic risk and, depending on the results, the age at which they should be invited for screening could be calculated'.

Breast cancer is the most commonly diagnosed cancer in the UK. In England, each year almost 31,000 women between the ages of 35 and 79 are diagnosed with the disease. Routine screening is currently offered to all women over the age of 50. Prostate cancer is the most common cancer in men and 37,000 men are diagnosed each year in the UK. Aggressive forms of the cancer require treatment to prevent the cancer from spreading.

Using the new model could also improve the detection of more aggressive cancers by identifying those at high risk. Dr Pashayan said: 'This approach means that screening women at high risk of the disease when they are younger will pick up some cancers earlier. These cancers tend to be more aggressive so the earlier they are picked up the better'.

Professor Paul Pharaoh, one of the authors of the study, said: 'Even though our analysis is based on a theoretical model… it still shows that personalised screening has the potential to reduce the disadvantages of a screening programme without losing any of its benefits. We now need more research'.

The study was published in the British Journal of Cancer and was funded by Cancer Research UK and COGS, a project funded by the European Commission.

SOURCES & REFERENCES
Cancer research UK press release | 11 May 2011
 
PHG Foundation | 11 May 2011
 
Scotsman | 11 May 2011
 
International Federation of Gynaecology and Obstetrics (FIGO) | 12 May 2011
 
British Journal of Cancer | 05 April 2011
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

08 October 2012 - by Dr Lucy Freem 
A streamlined method to find disease-causing single gene mutations has been developed to aid diagnosis of critically ill infants...
15 May 2012 - by Sarah Pritchard 
A DNA test for men with prostate cancer could indicate whether their cancer is likely to recur after treatment, and if so, how aggressively, say researchers from the University of Pittsburg School of Medicine, USA...
05 December 2011 - by Sarah Pritchard 
Two gene rearrangements associated with prostate and lung cancer could also be behind five to seven percent of all breast cancers, according to US scientists...
03 October 2011 - by Sarah Pritchard 
Sequencing tissue samples from patients with deadly forms of prostate cancer has revealed previously undefined, drug-resistant tumour types that are ten times more mutated than other varieties, report researchers. The findings could help scientists develop screening methods and treatments specific to these 'hypermutated' forms of the disease...
12 September 2011 - by Dr Zara Mahmoud 
Using nurses to pre-screen people for genetic risk of cancer, cardiac or endocrine disease before they're sent to specialist services can reduce referrals by up to 75 percent, a preliminary trial has found....

03 May 2011 - by Mehmet Fidanboylu 
Two US studies have demonstrated how whole-genome screening can help improve cancer treatment and diagnosis. The researchers claim to have taken a major step towards using this type of screening to help predict patients' responses to different treatments based on their genetics...
07 March 2011 - by Dr Jay Stone 
Scientists at Queen's University, Belfast, have developed a new targeted gene therapy for the treatment of breast cancer....
13 September 2010 - by Chris Chatterton and Jay Stone 
A group of international researchers have become the first to link the cumulative effects of single nucleotide polymorphisms (SNP) in genes responsible for the production of oestrogen, to a woman's risk of developing common breast and uterine cancers....
09 August 2010 - by Chris Chatterton and Louise Mallon 
A large prospective study has discovered new genetic variants associated with an increased risk of breast cancer....
09 August 2010 - by Sarah Pritchard 
A UK study has revealed that breast cancer patients who have the POLQ gene are eight times more likely to suffer from recurrence after treatment compared to patients who do not carry the gene....

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust
Advertise your products and services HERE - click for further details

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation